Novel 1% glucose isotonic electrolyte solution improves kid's safety during intraoperative period: Study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-11-27 03:30 GMT   |   Update On 2021-11-27 03:30 GMT

Novel 1% glucose isotonic electrolyte solution is beneficial as intraoperative fluid therapy in children, according to a recent study published in the Journal of International Medical Research. Fluid therapy is fundamental for safe intraoperative anaesthesia management in children. Inappropriate fluid management can result in several serious complications, including brain damage...

Login or Register to read the full article

Novel 1% glucose isotonic electrolyte solution is beneficial as intraoperative fluid therapy in children, according to a recent study published in the Journal of International Medical Research.

Fluid therapy is fundamental for safe intraoperative anaesthesia management in children. Inappropriate fluid management can result in several serious complications, including brain damage and mortality. Wider intraoperative glycemic fluctuation is associated with an increased incidence of postoperative acute kidney injury after pediatric cardiac surgery. Perioperative hyperglycemia is associated with poor outcomes, including surgical site infections and increased length of hospital stay; hence, glycemic control remains an important consideration in patients undergoing surgery. Hypotonic fluids can cause hyperglycemia and hyponatremia; thus, they should be avoided intraoperatively. Numerous studies and reports stated that physiologically composed isotonic electrolyte solutions containing 1% to 2% glucose are safe for intraoperative maintenance infusion in children. Isotonic solutions are better than hypotonic solutions in children requiring maintenance intravenous infusion in terms of their sodium content.

An appropriate electrolyte solution is important for safe intraoperative anesthesia management in children. This trial assessed the effectiveness of a novel 1% glucose isotonic electrolyte solution in intraoperative fluid therapy in children.

This trial analyzed data from 100 patients aged older than 1 month with an ASA score of I to II who received general anesthesia. Patients were randomly assigned to receive either the novel electrolyte solution (containing glucose, sodium, potassium, chloride, and bicarbonate) or lactated Ringer's solution intraoperatively as a maintenance fluid. Patient demographics and the results of blood gas analysis at 1, 2, and 3 hours were documented, and changes in glucose and electrolyte concentrations and the acid–base status were analyzed.

The Results of the study are as follows:

During infusion of the novel solution, the glucose and potassium concentrations were stable. Conversely, the solution was linked to increased sodium levels but decreased bicarbonate levels, although both changes were within the physiological ranges. In addition, pH remained stable during the intraoperative period. Hypoglycemia, hyperglycemia, hyponatremia, or hypernatremia was not detected.

Thus, the researchers concluded that the novel 1% glucose isotonic electrolyte solution helped to maintain glucose and electrolyte concentrations and acid–base stability, and it may therefore improve children's safety during the intraoperative period.

Reference:

Effectiveness of a novel 1% glucose isotonic electrolyte solution for intraoperative fluid therapy in children: a randomized controlled trial by Zheng-Zheng Gao et al. published in the Journal of International Medical Research.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593312/


Tags:    
Article Source : Journal of International Medical Research

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News